Zarmo Medical Consulting ApSActive

CVR 14919449Founded 1991

Key figures

178.785 kr.+89,8%
Gross profit 2025/26
+89,8%
Average annual growth 2024/25–2025/26
050 k100 k150 k200 k2024/252025/26

Key ratios

2025/26
Balance sheet structure
Current assetsNon-current assetsLiabilities and provisionsEquity
0200 k400 k600 k2024/252025/26

Dividends

from the annual report
2025/26

Proposed dividend for the financial year 79.400 kr. (71% of the profit for the year).

History
2025/2679.400 kr.
2024/2567.500 kr.

Proposed dividend from the annual report's profit allocation (normally paid the following year). If there is no proposal, the dividend paid according to the statement of changes in equity is shown.

Financial statements2025–2026
2024/252025/26
Balance sheet — assets
Cash and cash equivalents259.627294.905
Total current assets447.233481.807
Total non-current assets——
Total assets447.233481.807
Balance sheet — liabilities and equity
Current liabilities85.31556.058
Non-current liabilities019.054
Total liabilities85.31575.112
Share capital125.000125.000
Retained earnings of previous periods169.418202.295
Profit for the year-14.501112.277
Total equity361.918406.695
Income statement
Gross profit94.216178.785
Operating profit14.216178.785
Profit before income tax-14.501144.331
Profit for the reporting year-14.501112.277
Labour costs80.0000
Depreciation of non-current assets——
Other indicators
Employees11
Dividends67.50079.400

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

About the company

Annual report 2026

Selskabets væsentligste aktiviteter er at drive konsulentvirksomhed samt investering i værdipapirer. Ved konsulentvirksomhed forstås det ved at rådgive andre lægepraksis omkring behandling af patienter indenfor lægegerningen.

Excerpt from the management's review in the latest annual report.

Zarmo Medical Consulting ApS — cvrprofil.dk